Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases

Zoran Radić, Rakesh K. Sit, Zrinka Kovarik, Suzana Berend, Edzna Garcia, Limin Zhang, Gabriel Amitai, Carol Green, Božica Radić, Valery V. Fokin, K. Barry Sharpless, Palmer Taylor

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, 1H NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.

Original languageEnglish
Pages (from-to)11798-11809
Number of pages12
JournalJournal of Biological Chemistry
Volume287
Issue number15
DOIs
Publication statusPublished - 6 Apr 2012
Externally publishedYes

Fingerprint

Cholinesterase Reactivators
Oximes
Organophosphates
Acetylcholinesterase
Pharmacokinetics
Hydrolysis
Acetylthiocholine
Azepines
Sarin
Paraoxon
Structural optimization
Blood-Brain Barrier
Ionization
Amines
Toxicity
Spectrum Analysis
Nuclear magnetic resonance
RS194B
Spectroscopy

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Radić, Z., Sit, R. K., Kovarik, Z., Berend, S., Garcia, E., Zhang, L., ... Taylor, P. (2012). Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. Journal of Biological Chemistry, 287(15), 11798-11809. https://doi.org/10.1074/jbc.M111.333732

Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. / Radić, Zoran; Sit, Rakesh K.; Kovarik, Zrinka; Berend, Suzana; Garcia, Edzna; Zhang, Limin; Amitai, Gabriel; Green, Carol; Radić, Božica; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer.

In: Journal of Biological Chemistry, Vol. 287, No. 15, 06.04.2012, p. 11798-11809.

Research output: Contribution to journalArticle

Radić, Z, Sit, RK, Kovarik, Z, Berend, S, Garcia, E, Zhang, L, Amitai, G, Green, C, Radić, B, Fokin, VV, Sharpless, KB & Taylor, P 2012, 'Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases', Journal of Biological Chemistry, vol. 287, no. 15, pp. 11798-11809. https://doi.org/10.1074/jbc.M111.333732
Radić, Zoran ; Sit, Rakesh K. ; Kovarik, Zrinka ; Berend, Suzana ; Garcia, Edzna ; Zhang, Limin ; Amitai, Gabriel ; Green, Carol ; Radić, Božica ; Fokin, Valery V. ; Sharpless, K. Barry ; Taylor, Palmer. / Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. In: Journal of Biological Chemistry. 2012 ; Vol. 287, No. 15. pp. 11798-11809.
@article{2cc02c6cd7be4bdaa2384f99c1fc7367,
title = "Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases",
abstract = "We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, 1H NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.",
author = "Zoran Radić and Sit, {Rakesh K.} and Zrinka Kovarik and Suzana Berend and Edzna Garcia and Limin Zhang and Gabriel Amitai and Carol Green and Božica Radić and Fokin, {Valery V.} and Sharpless, {K. Barry} and Palmer Taylor",
year = "2012",
month = "4",
day = "6",
doi = "10.1074/jbc.M111.333732",
language = "English",
volume = "287",
pages = "11798--11809",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "15",

}

TY - JOUR

T1 - Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases

AU - Radić, Zoran

AU - Sit, Rakesh K.

AU - Kovarik, Zrinka

AU - Berend, Suzana

AU - Garcia, Edzna

AU - Zhang, Limin

AU - Amitai, Gabriel

AU - Green, Carol

AU - Radić, Božica

AU - Fokin, Valery V.

AU - Sharpless, K. Barry

AU - Taylor, Palmer

PY - 2012/4/6

Y1 - 2012/4/6

N2 - We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, 1H NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.

AB - We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, 1H NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.

UR - http://www.scopus.com/inward/record.url?scp=84859516990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859516990&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.333732

DO - 10.1074/jbc.M111.333732

M3 - Article

VL - 287

SP - 11798

EP - 11809

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 15

ER -